The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
NCT01211041 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2011-04-25
Summary
Candida albicans is the most common and important clinical fungal pathogen. Our previous surveillance disclosed that fluconazole could induce different morphological changes in clinical strains. Our current study on C. albicans causing candiuria disclosed that renal insufficiency , diabetes mellitus, respiratory failure and uremia were risk factors of treatment failure. However, we also found results of E-test drug susceptible test could not predict outcome. Hence, retrospective analysis of 31 months period, cases that had C. albicans inducing candidemia were reviewed and 60 cases were enrolled for morphological study and potential virulent gene analysis.
This study is designed to clarity the clinical meaning of morphological form and virulent genes on candidemia. To do this study is probably helpful for treatment of candidiasis.
Conditions
- Candidemia Prognostic Factor and Mycobiological Analysis.
Sponsors & Collaborators
-
Taipei Medical University WanFang Hospital
lead OTHER
Principal Investigators
-
Tsong-Yih Ou · Taipei Medical University WanFang Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-07-31
- Completion
- 2011-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
NCT00721487 ·Status: COMPLETED
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
Changing Patterns of Candida Infections in Urban Medical Centers
NCT00366223 ·Status: COMPLETED
-
Epidemiological Study of Vulvovaginal Candidiases Strain Types and Risk Factors Among Gynecological Outpatients in China
NCT06200389 ·Status: NOT_YET_RECRUITING
-
Prevalence and Epidemiology of Nosocomial Candidaemia and Antifungal Susceptibility Patterns in an Italian Tertiary-Care Hospital
NCT00903526 ·Status: UNKNOWN
-
A Multicenter Observational Study of Invasive Candida Infections Among ICU Patients in China
NCT01253954 ·Status: UNKNOWN
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Immunological Interaction Between the Host and Candida Albicans Biofilm
NCT01919931 ·Status: COMPLETED
-
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia
NCT00189709 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Study of a Short Duration Therapy for Candidemia
NCT06859671 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Early- and Late-onset Candidemia
NCT01406093 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Candida Spp. in the Lower Respiratory Tract: Harmless Residents or Pathogen?
NCT00786903 ·Status: COMPLETED
-
A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis
NCT01176058 ·Status: TERMINATED ·Phase: PHASE3
-
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 ·Status: COMPLETED ·Phase: PHASE3
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week
NCT00537888 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004808 ·Status: COMPLETED ·Phase: PHASE2
-
Vulvovaginal Candidiasis in Canadian Females
NCT04930107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins
NCT01213823 ·Status: TERMINATED
-
Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)
NCT01490138 ·Status: UNKNOWN